Mankind Pharma Limited
MANKINDDrug Manufacturers - Specialty & Generic
₹2,469.30−0.83%As of Oct 29vs prior close
- Market cap
- $10.7B
- P/E (TTM)
- 45.5×
- P/E (FY1)
- 42.0×
- From 52W high
- −5.68%
- EPS (LTM)
- ₹54.24
- Revenue (LTM)
- ₹153.8B
- Net margin
- 14.58%
Nomior Score
55
Steady ProfileTop 37% of the scored universe
Growth64
Quality60
Value38
Momentum53
Resilience55
Growth
+17.73%revenue a year over 3 fiscal years
YE23 ₹87.5BLTM ₹153.8B
Connections
Revenue to profitYE26
13% of revenue became net profit, down 3 pts on a year.